If Eli Lilly Grows At 10% a Year, Here’s What $1,000 Becomes By 2030

Eli Lilly just posted 47.7% revenue growth and its weight-loss drugs are reshaping global healthcare, but whether that momentum turns a four-year investment into a windfall or a disappointment depends on factors most investors overlook.